Matches in Wikidata for { <http://www.wikidata.org/entity/Q70136948> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q70136948 description "artikull shkencor i botuar më 01 janar 1991" @default.
- Q70136948 description "artículu científicu espublizáu en xineru de 1991" @default.
- Q70136948 description "im Jahr 1991 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70136948 description "scientific article published on 01 January 1991" @default.
- Q70136948 description "wetenschappelijk artikel" @default.
- Q70136948 description "наукова стаття, опублікована в січні 1991" @default.
- Q70136948 name "[Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors]" @default.
- Q70136948 name "[Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors]" @default.
- Q70136948 type Item @default.
- Q70136948 label "[Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors]" @default.
- Q70136948 label "[Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors]" @default.
- Q70136948 prefLabel "[Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors]" @default.
- Q70136948 prefLabel "[Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors]" @default.
- Q70136948 P1433 Q70136948-E6367FF0-B32B-4707-9DCA-781580924775 @default.
- Q70136948 P1476 Q70136948-A0B1FC55-15E8-4E9A-A212-CF1A736B7237 @default.
- Q70136948 P2093 Q70136948-0F45F416-6C7C-4F7E-AAA0-5E6F8F1CBD0E @default.
- Q70136948 P2093 Q70136948-134DDF74-D355-434F-A852-A22BDAC89041 @default.
- Q70136948 P2093 Q70136948-232A8284-3813-4AAE-AF70-D60C6B2BA03F @default.
- Q70136948 P2093 Q70136948-85352482-34A6-4F05-826D-04A4CABA1577 @default.
- Q70136948 P2093 Q70136948-A72C4BB9-D574-4C15-85B5-9E647DF76B95 @default.
- Q70136948 P2093 Q70136948-E2CEBED6-1771-4775-B896-40F1C79CD62F @default.
- Q70136948 P2093 Q70136948-F3743211-345F-4BC0-AFF9-560D594A69CB @default.
- Q70136948 P304 Q70136948-1FF772B1-9DBF-4E6C-9B8A-F81A74620896 @default.
- Q70136948 P31 Q70136948-99C0F87F-4D0D-4767-A433-D49DC976770F @default.
- Q70136948 P433 Q70136948-D2136AF9-2D34-4273-86B3-A68A7DB47F0B @default.
- Q70136948 P478 Q70136948-E398C3EF-60FE-4C5F-B689-08F201F0018F @default.
- Q70136948 P577 Q70136948-BFA4FDA1-B0CE-4B66-B4F7-F52F164A75A8 @default.
- Q70136948 P698 Q70136948-7F377945-0D15-48FE-A1AF-61F1423B8E7A @default.
- Q70136948 P921 Q70136948-9DDBEC7B-1210-49EA-90CD-6EEF9235EAA3 @default.
- Q70136948 P698 2014029 @default.
- Q70136948 P1433 Q26841888 @default.
- Q70136948 P1476 "[Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors]" @default.
- Q70136948 P2093 "Abe M" @default.
- Q70136948 P2093 "Akimoto M" @default.
- Q70136948 P2093 "Hirakawa H" @default.
- Q70136948 P2093 "Kumagai K" @default.
- Q70136948 P2093 "Mori S" @default.
- Q70136948 P2093 "Nishihira T" @default.
- Q70136948 P2093 "Ohuchi N" @default.
- Q70136948 P304 "64-74" @default.
- Q70136948 P31 Q13442814 @default.
- Q70136948 P433 "1" @default.
- Q70136948 P478 "92" @default.
- Q70136948 P577 "1991-01-01T00:00:00Z" @default.
- Q70136948 P698 "2014029" @default.
- Q70136948 P921 Q1427096 @default.